ATP1
S. cerevisiae
F1F0 ATP synthase subunit alpha
What the model saw
Gene: ATP1 Organism: Saccharomyces cerevisiae Known functions: F1F0 ATP synthase subunit alpha. ADP binding. ATP binding. ATP hydrolysis activity. adenyl ribonucleotide binding. proton-transporting ATP synthase activity, rotational mechanism.
View unredacted entry
F1F0 ATP synthase subunit alpha. ADP binding. ATP binding. ATP hydrolysis activity. adenyl ribonucleotide binding. proton-transporting ATP synthase activity, rotational mechanism.
Solver output
ATP1 encodes the alpha subunit of the mitochondrial F1F0 ATP synthase, which is the catalytic core responsible for oxidative phosphorylation-coupled ATP synthesis via a rotational mechanism driven by the proton gradient across the inner mitochondrial membrane. Proper function of this complex is essential for maintaining mitochondrial membrane potential and efficient ATP production, both of which decline with age and are hallmarks of mitochondrial dysfunction. In S. cerevisiae, loss of mitochondrial ATP synthase activity leads to petite formation, loss of mitochondrial DNA integrity, and impaired respiratory capacity, all of which are associated with shortened replicative and chronological lifespan. Additionally, the proton-transporting activity of ATP synthase is linked to regulation of mitochondrial morphology and cristae structure, which are increasingly recognized as determinants of longevity. Maintenance of robust ATP synthase function thus supports energy homeostasis and opposes age-associated mitochondrial decline, placing ATP1 as a pro-longevity gene.
GenAge curators classify each gene's normal function as promoting (Pro-Longevity) or opposing (Anti-Longevity) longevity, based on synthesis across studies. Loss-of-function effects can vary from this depending on the manipulation.
Advisor judgment
The model predicted pro_longevity with 0.82 confidence, but the ground truth is anti_longevity. The model's reasoning is plausible on the surface — ATP1 encodes the alpha subunit of F1F0 ATP synthase, and the model correctly describes its biochemical role. However, the model made a logical leap that because ATP synthase is important for energy production, its loss would shorten lifespan, making it pro_longevity. In reality, ATP1 is classified as anti_longevity in GenAge, meaning its deletion or reduction likely extends lifespan. This is consistent with findings in yeast where reduced mitochondrial respiration and TOR-related pathways can extend lifespan (e.g., caloric restriction mimicry). The model failed to consider that reduced ATP synthase activity could extend lifespan through mechanisms like reduced ROS production, reduced TOR signaling, or metabolic reprogramming. The model's mechanistic reasoning was confidently wrong — it assumed that essential metabolic genes are always pro_longevity, which is not the case in longevity biology where reduced activity of key metabolic enzymes often extends lifespan.
Raw API responses
solver
{
"reasoning": "ATP1 encodes the alpha subunit of the mitochondrial F1F0 ATP synthase, which is the catalytic core responsible for oxidative phosphorylation-coupled ATP synthesis via a rotational mechanism driven by the proton gradient across the inner mitochondrial membrane. Proper function of this complex is essential for maintaining mitochondrial membrane potential and efficient ATP production, both of which decline with age and are hallmarks of mitochondrial dysfunction. In S. cerevisiae, loss of mitochondrial ATP synthase activity leads to petite formation, loss of mitochondrial DNA integrity, and impaired respiratory capacity, all of which are associated with shortened replicative and chronological lifespan. Additionally, the proton-transporting activity of ATP synthase is linked to regulation of mitochondrial morphology and cristae structure, which are increasingly recognized as determinants of longevity. Maintenance of robust ATP synthase function thus supports energy homeostasis and opposes age-associated mitochondrial decline, placing ATP1 as a pro-longevity gene.",
"confidence": 0.82,
"key_pathways": [
"oxidative phosphorylation / F1F0 ATP synthase complex",
"mitochondrial membrane potential maintenance",
"mitochondrial cristae organization"
],
"mechanism_class": "mitochondrial_dysfunction",
"longevity_influence": "pro_longevity"
}advisor
{
"notes": "The model predicted pro_longevity with 0.82 confidence, but the ground truth is anti_longevity. The model's reasoning is plausible on the surface — ATP1 encodes the alpha subunit of F1F0 ATP synthase, and the model correctly describes its biochemical role. However, the model made a logical leap that because ATP synthase is important for energy production, its loss would shorten lifespan, making it pro_longevity. In reality, ATP1 is classified as anti_longevity in GenAge, meaning its deletion or reduction likely extends lifespan. This is consistent with findings in yeast where reduced mitochondrial respiration and TOR-related pathways can extend lifespan (e.g., caloric restriction mimicry). The model failed to consider that reduced ATP synthase activity could extend lifespan through mechanisms like reduced ROS production, reduced TOR signaling, or metabolic reprogramming. The model's mechanistic reasoning was confidently wrong — it assumed that essential metabolic genes are always pro_longevity, which is not the case in longevity biology where reduced activity of key metabolic enzymes often extends lifespan.",
"failure_mode": "confident_wrong",
"answer_correct": false,
"mechanism_correct": false,
"reasoning_quality": 2,
"ground_truth_questionable": false
}